Wolf Popper LLP Continues its Investigation on Behalf of Investors in Harmony Biosciences Holdings, Inc.
Harmony Biosciences(HRMY) Newsfilter·2024-04-25 19:00Harmony Biosciences Holdings, Inc.调查 - Wolf Popper LLP正在调查Harmony Biosciences Holdings, Inc.（"Harmony"）普通股（NASDAQ:HRMY）的潜在证券欺诈索赔[1] - Scorpion Capital发布了一份短卖报告，指控Harmony的WAKIX药物存在严重风险，FDA收到了大量严重不良事件报告[3] - Harmony的股价在短卖报告发布后下跌25.8%[3] - Wolf Popper已经成功为被欺诈投资者追回了数十亿美元[5]